Parallax Volatility Advisers
AVXL icon

Parallax Volatility Advisers’s Anavex Life Sciences AVXL Stock Holding History

Parallax Volatility Advisers’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,670
Closed -$18K – 2265
2017
Q4 		$18K Buy
+5,670
New +$22.3K ﹤0.01% 3694

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Parallax Volatility Advisers's AVXL Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Anavex Life Sciences (AVXL) in Q1 2018, closing a stake of 5,670 shares — an estimated $18K sold.

Parallax Volatility Advisers first reported a position in AVXL in Q4 2017 and held it in 1 quarter. The position peaked at $18K in Q4 2017. 58 funds tracked by Wall St. Rank hold AVXL as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Anavex Life Sciences position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 5,670 Anavex Life Sciences shares in Q1 2018, an estimated $18K.
  • Parallax Volatility Advisers first reported a position in Anavex Life Sciences in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Anavex Life Sciences position peaked at $18K in Q4 2017.
  • 58 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.